Back
Viridian Therapeutics Stock Price Chart
Sell
27
VRDN
Viridian Therapeutics
Last Price:
11.95
Seasonality Move:
-8.56%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRDN is experiencing selling pressure, which indicates risk of future bearish movement.
Viridian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.24 | Sell |
| 20-day SMA: | 13.58 | Sell |
| 50-day SMA: | 14.82 | Sell |
| 200-day SMA: | 16.9 | Sell |
| 8-day EMA: | 12.36 | Sell |
| 20-day EMA: | 13.18 | Sell |
| 50-day EMA: | 14.62 | Sell |
| 200-day EMA: | 17.53 | Sell |
Viridian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 31.49 | Sell |
| Chaikin Money Flow: | -355305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.46 - 14.72) | Sell |
| Bollinger Bands (100): | (14.26 - 19.88) | Sell |
Viridian Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics Stock
Is Viridian Therapeutics Stock a Buy?
- Viridian Therapeutics share price is 11.95 while VRDN 8-day simple moving average is 12.24, which is a Sell signal.
- The stock price of VRDN is 11.95 while Viridian Therapeutics 20-day SMA is 13.58, which makes it a Sell.
- Viridian Therapeutics 50-day simple moving average is 14.82 while VRDN share price is 11.95, making it a Sell technically.
- VRDN stock price is 11.95 and Viridian Therapeutics 200-day simple moving average is 16.90, creating a Sell signal.
VRDN Technical Analysis vs Fundamental Analysis
Sell
27
Viridian Therapeutics (VRDN)
is a Sell
Is Viridian Therapeutics a Buy or a Sell?
-
Viridian Therapeutics stock is rated a Sell
The current Viridian Therapeutics [VRDN] share price is $11.95. The Score for VRDN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Viridian Therapeutics Stock Info
Market Cap:
762.68M
Price in USD:
11.95
Share Volume:
626.01K
Viridian Therapeutics 52-Week Range
52-Week High:
28.35
52-Week Low:
10.93
Sell
27
Viridian Therapeutics (VRDN)
is a Sell
Viridian Therapeutics Share Price Forecast
-
What is the Viridian Therapeutics stock price today?
The Viridian Therapeutics stock price is 11.95 USD today. -
Will VRDN stock go up or go down?
Viridian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Viridian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics is overvalued.
Is Viridian Therapeutics Stock a Buy?
- Viridian Therapeutics share price is 11.95 while VRDN 8-day exponential moving average is 12.36, which is a Sell signal.
- The stock price of VRDN is 11.95 while Viridian Therapeutics 20-day EMA is 13.18, which makes it a Sell.
- Viridian Therapeutics 50-day exponential moving average is 14.62 while VRDN share price is 11.95, making it a Sell technically.
- VRDN stock price is 11.95 and Viridian Therapeutics 200-day simple moving average is 17.53, creating a Sell signal.
Fundamental Analysis of Viridian Therapeutics
Is Viridian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.09 per share, an increase this year of $1.15 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Viridian Therapeutics
Should I short Viridian Therapeutics stock?
- VRDN Moving Average Covergence Divergence (MACD) indicator is -0.84, suggesting Viridian Therapeutics is a Sell
- Viridian Therapeutics Relative Strength Index (RSI) is 31.49, which suggest Viridian Therapeutics is oversold
- The Bollinger Bands (25) for Viridian Therapeutics is (12.46 - 14.72), which suggest Viridian Therapeutics is a Sell
- The Bollinger Bands (100) for Viridian Therapeutics is (14.26 - 19.88), which suggest Viridian Therapeutics is a Sell
* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.